Always putting healthier
lives first
scroll
News
-
Sawai Group Reports First Quarter FY2022 Financial Results
-
Sawai Group Reports FY2021 Financial Results
-
Sawai Group Reports Third Quarter FY2021 Financial Results
-
Posted the Supplementary Document Associated with Conclusion of Asset Transfer (Acquisition) Agreement
-
Sawai Group Holdings and ORIX Agree on Conclusion of Transfer Agreement with Kobayashi Kako -Toward Early Establishment of In-house Annual Production Capacity of 20 Billion Tablets or More-
-
Sawai Receives Approvals for Six Generic Drugs with 13 Strengths
-
Sawai Announces Listing of Five Generic Drugs with 11 Strengths
-
Sawai Receives Approvals for Seven Generic Drugs with 14 Strengths
-
Sawai Announces Listing of Five Generic Drugs with Nine Strengths
-
Sawai Group Holdings and ORIX Agree on Conclusion of Transfer Agreement with Kobayashi Kako -Toward Early Establishment of In-house Annual Production Capacity of 20 Billion Tablets or More-
Company Information
